Whole body hyperthermia
In contrast to active fever therapy, with whole body hyperthermia the body itself does not produce the heat with a fever. While the patient lies in a “waermebett” (warming bed), the body is heated to about 40°C from an infrared lamp. This process weakens the cancer cells that subsequently cannot withstand the additional therapies given and die off.
Local and regional hyperthermia
Apparatuses that can target specific areas or regions of the body are used where the tumor is located. Using electromagnetic fields, the temperature in and around the tumor can reach 43°C without an increase in overall body temperature. The cancer cells are damaged! This treatment is especially helpful for older patients who may not be able to tolerate high body temperatures.
Why does hyperthermia promise to be a better method for the future?
It doesn’t have negative side effects.
Once the tumor temperature reaches 42.5°C the body produces special proteins that attack the tumor.
Immune responses are activated and not suppressed, as is the case with radiation and chemotherapy.
The high temperature creates a metabolic disturbance with blood vessel blockage and decreased blood supply to the tumor resulting in its final destruction.
It is known that high temperatures increase the effects of chemotherapy and radiation. Therefore, by using hyperthermia only a small amount of chemotherapy is needed which minimizes the harmful side effects of the chemo.
Tumors that have become insensitive to chemo can be re-sensitized through hyperthermia.
One cycle of this treatment includes 6 to 10 sessions given once or twice a week. Hyperthermia can be performed on an outpatient basis. However inpatient is preferred since supplemental therapies can be added as needed.
Caution – this treatment must be chosen judiciously – it is not for every patient or every tumor. Careful consideration must be given when deciding the efficacy of this versus other methods and treatments.
Cannot be used for treating patients who have a pacemaker
Cannot be used for treating patients whose tumor is anatomically unaccessible
Cannot be used for treating patients who have any metal implants
Cannot be used for treating patients who have large areas of burned skin
The forerunner to hyperthermia is fever therapy. Coley, Issels, and others have found active fever therapy particularly effective in cancer treatment; we have experienced the same.
It breaks through reaction blockades, speeds up the elimination of toxins from the body, and especially, stimulates the immune system in general. Unlike passive hyperthermia where the body or the tumor is heated from the outside by appropriate devices, active fever therapy induces a fever up to and above 40°C by intravenous administration of bacterial lipopolysaccharides. The sole purpose of active fever therapy is not so much a matter of killing tumor cells. To achieve this, temperatures of around 43°C (109.4 Fahrenheit) would have to be generated in the cancerous tissue which, of course, is humanly unfeasible. However, the advantage of active fever therapy comes from the changes in the cell that makes supplemental therapies much more effective.